Bridging Studies For 505(b)(2) Approval

The sponsor required assistance with a 505(b)(2) application for a well established compound where a different salt of the active ingredient has been proposed. There were no claims of the product being clinically better by this modification to the active ingredient.

Click here to read our 505(b)(2) early phase fact sheet